Objective: Exogenous catecholamine exposure has been associated with p38 mitogen-activated protein kinase (MAPK) and cardiac hypertrophy. In this study, we investigated the regulation of p38 MAPK in cardiac remodeling elicited by endogenous adrenergic mechanisms. Methods: Transgenic male and female mice with fourfold phospholamban (PLB) overexpression exhibited enhanced circulating norepinephrine (NE), as a physiological compensatory mechanism to attenuate PLB's inhibitory effects. This enhanced noradrenergic state resulted in left ventricular hypertrophy / dilatation and depressed function. Results: Male transgenics exhibited ventricular hypertrophy and mortality at 15 months, concurrent with cardiac p38 MAPK activation. Female transgenics, despite similar contractile dysfunction, displayed a temporal delay in p38 activation, hypertrophy, and mortality (22 months), which was associated with sustained cardiac levels of MAP Kinase Phosphatase-1 (MKP-1), a potent inhibitor of p38. At 22 months, decreases in cardiac MKP-1 were accompanied by increased levels of p38 activation. In vitro studies indicated that preincubation with 17-b-estradiol induced high MKP-1 levels, which precluded NE-induced p38 activation. Conclusion: These findings suggest that norepinephrine-induced hypertrophy is linked closely with p38 MAP kinase activation, which can be endogenously modulated through estrogen-responsive regulation of MKP-1 expression.
signaling may be critical to the remodeling process.
age group and gender, prior to quantitative immunoblotting Furthermore, in response to adrenergic input, recent studies [13] . Primary antibody was detected by peroxidase-conjuin adult cardiac myocytes have shown that activation of gated (ECL, Amersham) secondary antibody. Protein p38 may counterbalance the PKA-mediated positive conconcentrations were determined by the Bradford method tractile response by decreasing the myofilament respon-(Bio-Rad) with a BSA standard. siveness to calcium [5] .
The MAPK signaling pathway is tightly regulated by a 2 .3. In vivo echocardiographic measurement of cardiac family of dual-specificity phosphatases [6] . MAP Kinase function Phosphatase-1 (MKP-1), which potently deactivates p38 [7] , appears to be a critical determinant of p38-dependent Two-dimensional M-mode and color Doppler echocarhypertrophic growth in the heart. Indeed, transgenic overdiography was carried out as described [14] . expression of MKP-1 was associated with a suppressed p38 activation and hypertrophic response to either pressure 2 .4. Systolic blood pressure measurements overload or prolonged a-agonist infusion [8] . A more recent study has linked catecholamine production to presTail-cuff measurements of systolic blood pressure were sure overload hypertrophy, although the role of MKP-1 in assessed in male and female, wild-type (WT) and TG these hearts was not pursued [9] . Furthermore, MKP-1 animals at 3 months of age. Ten repetitive cycle measureprotein expression may be positively regulated by estrogen ments were averaged daily for five consecutive days to in cardiac myocytes [10] , suggesting that, in the context of obtain average systolic pressures for each mouse (n55 a hypertrophic stimulus, differential regulation of p38 animals per group). activity may exist between male and female hearts. Indeed a recent aortic banding pressure-overload model [11] demonstrated that estrogen replacement is associated with 2 .5. Plasma and tissue catecholamine levels reduced p38 activation and attenuated hypertrophy, but the involvement of MKP-1 was not explored. Thus, it remains Norepinephrine, epinephrine, and dopamine levels were unclear whether endogenous regulation of MKP-1 expresdetermined as previously described [12] (n56 animals for sion can suppress p38-mediated hypertrophic signaling in each group). response to endogenous catecholamine production, and whether gender can modulate this interaction amidst a 2 .6. MAP Kinase activation in cardiomyocyte prolonged adrenergic insult.
preparations To further address the role of MKP-1 in p38 signaling, in vivo, this study explored the remodeling mechanisms in Wild-type female mouse left ventricular cardiomyocytes a transgenic mouse model of fourfold PLB overexpression, were isolated [13] and resuspended in 1.8 mM (physiologiwhich develops a physiological, compensatory increase in 21 cal) Ca -Tyrode buffer (pH 7.3). Pooled myocyte prepacirculating norepinephrine [12] . Our data link endogenous rations (two hearts) were required for detection of actiadrenergic cardiotoxicity to p38 MAP Kinase activation vated MAP kinase levels. Equal volumes of carand to reduced MKP-1 protein levels. Moreover, estrogen diomyocytes were treated with either 1 mM norepinephrine may protect the heart from structural decompensation (NE), or 1 nM 17b-estradiol (E2) at 37 8C. A third group through induction of MKP-1 with subsequent suppression was preincubated with 1 nM E2 for 30 min at 37 8C and of p38 activation. treated with 1 mM NE. Aliquots were removed on ice and solubilized in equal volumes of deionized water and sample buffer (20% glycerol, 2% b-mercaptoethanol, 4% 2 . Methods SDS, 0.001% bromophenol blue, and 130 mmol / l TrisHCl (pH 6.8)) for 30 min. Samples were subjected to 2 .1. PLB transgenic animals SDS-PAGE on 10% polyacrylamide gels and transferred to nitrocellulose membranes (0.2 mm), as described [13] Transgenic FVB / N mice (TG) were generated using a (n54 per group, two determinations per n). 6.4-kb transgene containing the a-myosin heavy chain promoter, PLB cDNA, and the SV40 polyadenylation signal [12] . 2 .8. Statistical analysis females involved a possible delay in adrenergic signaling enhancement, an important compensatory mechanism in Data are presented as mean6S.E.M. The number (n) of this model [12] . As previously reported, male TG mice mice used is indicated with each figure. Statistical analyses exhibited high PLB phosphorylation levels (|ninefold were carried out using Student's t-test or two-way increase), which were linked to increased sympathetic ANOVA.
drive [12] . To determine whether similar PLB overexpression in female TG hearts might elicit comparable compensation, PLB phosphorylation was quantified, using site-3 . Results specific phosphorylation antibodies. The phosphorylation levels of both serine-16 (|10-fold) and threonine-17 3 .1. Early mortality in male and female transgenic mice (|fourfold) sites were substantially higher in female TG hearts (Fig. 1B) , similar to their male counterparts [12] . Phospholamban overexpression is associated with comThis increased phosphorylation at a PKA-dependent site pensatory increases in adrenergic drive to alleviate its prompted measurements of adrenergic drive in female inhibitory effects. However, chronic beta-adrenergic rehearts as a logical source for such increases. Myocardial ceptor activity results in cardiac hypertrophy, depressed norepinephrine (NE) was depleted by 18% (pg / mg: WT left ventricular function and premature mortality [12] . TG females, 1480680; TG females, 1100660; n56 hearts per males displayed an early mortality between 15 and 18 group, P,0.05) and plasma NE elevated by 50% in TG months (Fig. 1A) , which was associated with cardiac female hearts, compared to WT females (ng / ml: WT hypertrophy and fibrosis. Pulmonary congestion was not females, 2.860.3; TG females, 4.260.6; n55 hearts per evident as lung-to-body mass ratios were not significantly group, P,0.05). The relative adrenergic alterations were different between aging TG and WT mice (mg / g: WT, similar to the 18% decrease and 52% increase in male TG 5.1260.41; TG, 5.4160.23). The deaths of the TG mice myocardial and plasma NE, respectively [12] , indicating were sudden, suggesting that the cause of death may be that female TG mice possessed a comparable degree of related to the arrhythmic activity. Notably, female TGs increased catecholaminergic drive. Interestingly, proexhibit significantly (P,0.05) longer average lifespans panolol treatment for 10 weeks exerted no effect on left than male TGs (survival in months: males, 1660.4; ventricular fractional shortening (FS%) and the velocity of females, 21.360.7). There are no apparent differences in circumferential fiber shortening (Vcf ) in WTs, while these c the survival rates between WT females and males (Fig. parameters were significantly decreased compared to non-1A). The delayed mortality of female TGs prompted treated TG mice. This depressed function was associated inquiries into gender-dependent alterations in: (a) PLB with reduced PLB phosphorylation and increased inhibiexpression levels; (b) adrenergic drive; (c) left ventricular tion of SERCA [12] . function; and / or (d) chamber remodeling, each of which could contribute to the improved survival of female TGs.
.4. Depressed left ventricular and SR function in male and female transgenics .2. Phospholamban overexpression in male and female transgenic mice
The findings above indicate that the prolonged survival in female TG mice existed despite similar increases in PLB Calcium handling in the cardiomyocyte is largely depenprotein expression and catecholamine excess. We then dent upon SR function. To assess the degree of PLB investigated whether left ventricular function might be overexpression and the consequent SR functional effects, preserved in female hearts, thereby influencing their surthe protein levels of PLB, SERCA2, and calsequestrin vival. M-Mode and Doppler echocardiography was carried (CSQ) were determined by quantitative immunoblotting.
out at specific time-points (3, 15, and 22 months). ThreeThree-month-old WT males and females expressed similar month-old male and female TG mice possessed similar left levels of PLB and SERCA2. Age-matched male and ventricular function. Surprisingly, upon aging to 15 female TG hearts exhibited fourfold increases in PLB, months-the beginning of the mortality period in maleswhereas SERCA2 protein levels were unchanged, thereby female TGs exhibited nearly identical depressions in increasing the relative PLB / SERCA2 ratio to 4:1 in both contractile parameters as their male TG counterparts. [12] . Indeed, SERCA2 levels and PLB phosAnother possibility for the prolonged lifespan in TG phorylation were decreased in aging female TG hearts. PLB phosphorylation at Thr-17 showed a trend to be protein and functional alterations were evident in TG slightly higher than age-matched male TGs, but it was not females at 15 months, an early mortality did not accomstatistically different (Fig. 1C) . Thus, although comparable pany this functional decline. cardiac hypertrophy. Thus, decreases in MKP-1 protein and increases in p38 MAPK activation were temporally 3 .5. Left ventricular hypertrophy and dysfunction in associated with the development of hypertrophy and male and female transgenics premature mortality in this model of enhanced adrenergic drive. Evaluation of ERK phosphorylation, a second One salient feature of the cardiomyopathy observed in member of the MAPK signaling family and a potential male TG hearts was the development of left ventricular hypertrophic mediator, revealed significant (P.0.05) inhypertrophy and dilation at 15 months [12] . In this regard, creases in both male and female TG hearts (with respect to echocardiography revealed a clear departure in 15-month same-sex WTs). However, there was no significant evi-TG female hearts. Whereas 15-month male TG hearts dence of differential ERK activation between the genders developed a 32% increase in gravimetric LVM / BM ratio, (Fig. 3A) . 15-month females displayed no increase in either index of hypertrophy ( Fig. 2A) . Furthermore, left ventricles from 3 .8. Effects of norepinephrine and estrogen in isolated 15-month TG females were not dilated, as evidenced by a cardiomyocytes preserved end-diastolic dimension (EDD, Fig. 2B ), unlike their 15-month male counterparts. Upon aging to 22
To test the hypothesis that estrogen modulates hypermonths, female TGs developed substantial left ventricular trophic signaling, left ventricular myocytes from wild-type hypertrophy (33%) and chamber dilatation, which was female mice were isolated and treated with norepinephrine concurrent with their premature mortality ( Fig. 2A) .
(NE) and 17b-estradiol (E2). The treated myocytes were Hence, a transition was apparent from 15 months onward, harvested and subjected to quantitative immunoblotting to which precipitated the development of pathology in aging determine the degree of MAPK activation. Both NE and female TG hearts.
E2 were able to activate ERK1 / 2 (Fig. 4) . However, estrogen (alone and in combination with NE) achieved a 3 .6. Blood pressure measurements significant (P,0.05) prolongation of ERK1 / 2 activation (|1 h) compared to NE alone (Fig. 4A) . Recent studies To address whether the disparate hypertrophic patterns have implicated ERK-dependent phosphorylation of MKPin this model were due to gender-dependent differences in 1 to a rapid stabilization of the phosphatase in vitro [16] . hemodynamic loads, systolic tail-cuff blood pressures were When MKP-1 levels were assessed in E2-treated myocyte measured in young male and female animals. No signifipreparations, a significant, sustained increase in MKP-1 cant differences among male (mmHg: WT, 11762; TG, protein levels was observed, compared to NE alone (Fig. 4B). Immunoblots were also probed for levels of activated The development of cardiac hypertrophy involves mop38 MAP kinase. NE-treated cardiomyocytes exhibited a lecular signaling pathways that are responsive to both maximal activation of p38 MAP kinase at 15 min; howmechanical (i.e. pressure overload) and neurohormonal ever, E2 preincubation was able to suppress this NE-(i.e. catecholamines, endothelin, angiotensin II) imbalances induced p38 activation (Fig. 5) . It is critical to note that the [17] . A recent study of aortic constriction in catecholin vitro suppression of p38 activation was consistent with amine-deficient mice emphasized the dependence of pres-E2's stimulation of MKP-1 expression, which has been sure-overload hypertrophy upon adrenergic stimulation [9] . shown to potently deactivate p38 [7] .
In our model, the absence of blood pressure differences supports at least a partial role of catecholamines in inducing hypertrophy through the MAP kinase pathway, 4 . Discussion and specifically, p38 MAP Kinase. Recent in vitro findings in isolated cardiomyocytes suggested that the stimulatory This study represents, to our knowledge, the first in vivo effects of b2-AR on p38 MAPK are mediated by a PKAevidence that endogenous elevations in adrenergic drive dependent pathway [18] . These data imply that, in failing may lead to cardiac remodeling through p38 activation, human hearts, the selective downregulation of b1 receptors which is regulated, at least partially, by MKP-1 levels in a might allow norepinephrine to continue to activate p38 gender-dependent manner. Our data also suggest that through both a and b2 signaling. Similarly in this model, hypertrophy and left ventricular dysfunction may arise desensitization of adrenergic signaling [12] did not predistinctly, secondary to hormonal influence over cardiac clude increasing activation of p38 MAP Kinase. Future remodeling, and that gender may influence the progression investigations into altered b1 versus b2 signaling comof left ventricular hypertrophy in the context of chronically ponents may provide insight into p38 activation in adrenelevated adrenergic drive.
ergically-desensitized hearts. It is important to note that recent work [5] appears to calcineurin levels indicated |2.0-fold increase in both aged indicate that p38 activation alone may not be sufficient to male and female TG mice (data not shown), consistent induce hypertrophy, suggesting that other molecular mediwith the nearly identical SR protein and functional alteraators may be involved in this phenotype. Calcium cycling tions in both genders. defects have also been shown to trigger the onset of Cardiovascular disease variably affects different cohorts hypertrophic signaling, specifically through calcineurin, a of the population, particularly with respect to gender. calcium-dependent phosphatase [19] . The signaling acFemale patients with similar degrees of advanced, nontivities of calcineurin require perturbations in baseline ischemic left ventricular dysfunction exhibited improved calcium levels / cycling, and abnormalities of calciumsurvival rates over males [21] . In addition, female patients handling in the failing cardiomyocyte [20] are presumed to with aortic stenosis exhibited better preservation of systolic be critical to calcineurin's activation. Assessment of function and increased left ventricular hypertrophy versus males [22] [23] [24] . Similarly, aortic banding studies in rats signaling had ensued. Interestingly, gender appeared to revealed earlier transition to left ventricular chamber influence not only left ventricular hypertrophy, but also dilatation, eccentric hypertrophy, and diastolic dysfunction chamber dilatation, indicating effects on both the degree in males versus females [25, 26] . However, it is currently and the nature of hypertrophic growth. Indeed, it may be unclear whether estrogen is directly responsible for these important for females to regulate the development of disparities in left ventricular function and structural recardiac hypertrophy, since there is some evidence that modeling / hypertrophy [27] . In this study, male TG mice female patients with a similar degree of non-ischemic exhibited increased p38 MAPK activation at 3 months, hypertrophy as males exhibit higher mortality rates [28] . reflecting chronically enhanced adrenergic stimulation.
Notably, concurrent MKP-1 protein decline and p38 Although p38 activation in female transgenics was not activation in females occurred following the reported detected at 3 months, it was present at 15 and 22 months, menopausal period for mice (14-15 months) [29] . In this suggesting that a possible molecular 'brake' on p38 regard, rapid induction of MKP-1 by estrogen in isolated activation by MKP-1 was lifted, and that hypertrophic myocytes was observed in this and other studies [10] . Interestingly, a recent study [30] indicated that estrogen ders, it was unexpected to find the synchronous decline in may mediate p38-kinase inactivation via MKP-1 induction left ventricular performance dissociated from the cardiac in glomerular mesangial cells, suggesting a protective hypertrophic response between genders. Although left effect of estrogen in various target organs. However, other ventricular functional decline and hypertrophic growth factors contributing to the delayed p38 activation in may stem from the same precipitating insult (i.e. excess females may also exist, since there was no effect of gender adrenergic drive), they may diverge into distinctly upon baseline MKP-1 levels at 3 months of age, despite modulatable processes. Consistent with this observation, selective p38 activation in transgenic males. These may recent work by DiPaola et al. [37] captured a unique include PKA activation of a tyrosine phosphatase [31], or window, demonstrating that human hearts possessing left even Inhibitor-1 of Protein Phosphatase-1, which may lead ventricular hypertrophy in the absence of functional imto increased MAPK activation [18] . Moreover, we cannot pairment did not yet exhibit alterations in SR calciumrule out the possibility that other hormonal influences are handling protein levels, whereas functionally-impaired acting in this model. Notably, the beneficial effects of hypertrophic hearts did. Interestingly, the early mortality in estrogen against cardiac hypertrophy may be mediated by our transgenic model coincided with the development of interactions between this hormone and the renin-angiotenleft ventricular hypertrophy and dilatation, but not with SR sin system [32] [33] [34] .
protein alterations. These observations provide some inThe progressive functional impairment was predictably sight into the important transition from compensation (i.e. mirrored by decreases in SERCA2 protein and PLB hypertrophy without SR / functional alterations) to decomphosphorylation. These subcellular protein alterations, pensation (i.e. hypertrophy with SR / functional alterations) similar to previous observations upon hyperadrenergic in human heart failure [38]. stimulation [35] , were nearly identical between male and Together, our findings implicate MKP-1-dependent regfemale TGs. A non-significant trend existed for aging ulation of p38 activation as an integral component of female TGs to possess higher Thr-17 PLB phosphorylation catecholamine-induced hypertrophy. Moreover, gender-delevels. However, transgenic mice expressing mutant PLB, pendent modulation of MKP-1 may contribute to the which lacks a Thr-17 phosphorylation site (T17A), eximproved cardiac remodeling and survival rates observed hibited no alterations in basal contractile parameters or in females with left ventricular dysfunction. A more their b-adrenergic responses, indicating that phosphoryladetailed analysis of the temporal expression of p38 in tion of this residue may not serve a critical role [36] . In early-and late-stage hypertrophy may yield important light of similar SR and functional profiles between geninsights into the pathophysiology of this process. Further-
